Prevalence and Risk Factors of Persistent Hyperparathyroidism in Kidney Transplant Recipients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220803001

Enrollment

104

Registered

2022-08-03

Start date

2022-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent hyperparathyroidism in kidney transplant recipients. Persistent hyperparathyroidism, hyperparathyroidism, kidney transplant

Interventions

Patient with persistent hyperparathyroidism after kidney transplant ,Patient without persistent hyperparathyroidism after kidney transplant

Screening,Screening

Persistent hyperparathyroidism,No Persistent hyperparathyroidism

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years old 2. Received kidney transplant more than 1 year

Exclusion criteria

Exclusion criteria: 1. Multiple organ transplant 2. Previous parathyroidectomy 3. Renal allograft loss requiring dialysis 4. Pregnancy

Design outcomes

Primary

Measure	Time frame
persistent hyperparathyroidism at 12 months after kidney transplant serum parathyroid hormone	—

Secondary

Measure	Time frame
allograft funtion at 12 months after kidney transplant GFR	—

Countries

Thailand

Contacts

Public ContactKittrawee Kritmetapak

Faculty of Medicine, Khon Kaen University, Thailand

kittrawee@kku.ac.th0891863664

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026